Shield Therapeutics PLC on Thursday said it remains on track to meet its full-year revenue covenant target following strong sales of its iron deficiency treatment.
Jet2 PLC expects to deliver profit ahead of market expectations, after reporting a boost in revenue and pretax profit in its half-year results on Thursday....
The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News: